The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas (DCLP3)
A Pivotal Study of t:Slim X2 With Control-IQ Technology
Sponsor: DexCom, Inc.
This NA trial investigates Type 1 Diabetes Mellitus and is currently completed. DexCom, Inc. leads this study, which shows 15 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
15 versions recorded-
Jan 2026 — Present [monthly]
Completed NA
-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jun 2024 — Jul 2024 [monthly]
Completed NA
-
Jan 2023 — Jun 2024 [monthly]
Completed NA
▶ Show 10 earlier versions
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
-
May 2020 — Jan 2021 [monthly]
Completed NA
-
Feb 2020 — May 2020 [monthly]
Completed NA
-
Aug 2019 — Feb 2020 [monthly]
Completed NA
-
Jun 2019 — Aug 2019 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Nov 2018 — Jun 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Oct 2018 — Nov 2018 [monthly]
Recruiting NA
-
Aug 2018 — Oct 2018 [monthly]
Recruiting NA
-
Jul 2018 — Aug 2018 [monthly]
Recruiting NA
First recorded
Jun 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- DexCom, Inc.
- Jaeb Center for Health Research
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Roche Diagnostics GmbH
- Tandem Diabetes Care, Inc.
- University of Virginia
For direct contact, visit the study record on ClinicalTrials.gov .